QUDEXY

Drug UPSHER-SMITH LABORATORIES LLC
Total Payments
$12,345
Transactions
46
Doctors
30
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2023 $18.15 1 1
2022 $6.06 1 1
2021 $12,321 44 28

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $11,592 5 93.9%
Food and Beverage $577.47 40 4.7%
Consulting Fee $175.00 1 1.4%

Payments by Type

Research
$11,592
5 transactions
General
$752.47
41 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 4 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QUDEXY(R) XR IN THE PREVENTION OF MIGRAINE IN CHILDREN 6 TO 11 YEARS OF AGE UPSHER-SMITH LABORATORIES LLC $11,592 1

Top Doctors Receiving Payments for QUDEXY

Doctor Specialty Location Total Records
Unknown Jackson, MS $10,242 4
, MD Neurology with Special Qualifications in Child Neurology Philadelphia, PA $1,350 1
, MD Pediatrics Aurora, CO $175.00 1
, FNP-C Family Dallas, TX $47.40 4
, FNP Family Medicine Dallas, TX $47.39 4
, PA-C Medical Irwin, PA $34.42 1
, DO Internal Medicine Dallas, TX $32.57 1
, M.D Neurology Richardson, TX $23.71 1
, MD Neurology Dallas, TX $23.61 3
, M.D Neurology Dallas, TX $23.61 3
, NP Family Dallas, TX $23.60 3
, M.D Internal Medicine Greenville, AL $19.58 1
, M.D Neurology with Special Qualifications in Child Neurology Cincinnati, OH $18.15 1
, ARNP Family Navarre, FL $17.42 1
, M.D Family Medicine Navarre, FL $17.41 1
, M.D Family Medicine Daphne, AL $16.80 1
, M.D Internal Medicine Mobile, AL $16.80 1
, M.D Neurology Mobile, AL $16.80 1
, M.D Ophthalmology Daphne, AL $16.79 1
, M.D Internal Medicine Mobile, AL $16.79 1
, P.A Medical Plano, TX $16.39 1
, PA Family Medicine Carrollton, TX $16.39 1
, MD Family Medicine Plano, TX $16.39 1
William Calley Plano, TX $16.39 1
, APRN Nurse Practitioner Crestview Hills, KY $16.18 1

About QUDEXY

QUDEXY is a drug associated with $12,345 in payments to 30 healthcare providers, recorded across 46 transactions in the CMS Open Payments database. The primary manufacturer is UPSHER-SMITH LABORATORIES LLC.

Payment data is available from 2021 to 2023. In 2023, $18.15 was paid across 1 transactions to 1 doctors.

The most common payment nature for QUDEXY is "Unspecified" ($11,592, 93.9% of total).

QUDEXY is associated with 1 research study, including "A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 4 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QUDEXY(R) XR IN THE PREVENTION OF MIGRAINE IN CHILDREN 6 TO 11 YEARS OF AGE" ($11,592).